Clinical trial
A Study of ZN-c5 in Subjects With Breast Cancer
NCT03560531
Study timeline
Study start (actual)2018-11-30Date precision: day
Registry last updated2024-08-09
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Breast Cancerunresolved
Interventions
ZN-c5DRUG
PalbociclibDRUG · verified · RxNorm: palbociclib
Sponsors & collaborators
Zeno Alpha Inc.lead sponsor
Mapped research locations
New YorkNew York, United States2HoustonTexas, United States2BelgradeSerbia2Los AngelesCalifornia, United States1St LouisMissouri, United States1NashvilleTennessee, United States1SeattleWashington, United States1CharlestonSouth Carolina, United States1TucsonArizona, United States1BethesdaMaryland, United States1BudapestHungary1Saint PetersburgRussia1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03560531 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.